Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,626 | -22,625 | -16,151 | -10,061 | -4,476 |
| Depreciation Amortization | 73 | 191 | 117 | 43 | 3 |
| Accounts receivable | 24 | -400 | -349 | -342 | -318 |
| Other Working Capital | -1,251 | 1,403 | 1,204 | 113 | -872 |
| Other Operating Activity | 466 | 3,506 | 2,859 | 2,357 | 1,540 |
| Operating Cash Flow | $-7,314 | $-17,925 | $-12,320 | $-7,890 | $-4,123 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,197 | -70,562 | -30,129 | -26,260 | N/A |
| PPE Investments | N/A | -64 | -49 | -27 | -10 |
| Investing Cash Flow | $8,197 | $-70,626 | $-30,178 | $-26,287 | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 5,000 | 5,000 | 5,000 | 5,000 |
| Common Stock Issued | N/A | 97,870 | 47,589 | 47,841 | 51,580 |
| Financing Cash Flow | $N/A | $102,870 | $52,589 | $52,841 | $56,580 |
| Beginning Cash Position | 15,443 | 1,124 | 1,124 | 1,124 | 1,124 |
| End Cash Position | 16,326 | 15,443 | 11,215 | 19,788 | 53,571 |
| Net Cash Flow | $883 | $14,319 | $10,091 | $18,664 | $52,447 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,314 | -17,925 | -12,320 | -7,890 | -4,123 |
| Capital Expenditure | N/A | -64 | -49 | -27 | -10 |
| Free Cash Flow | -7,314 | -17,989 | -12,369 | -7,917 | -4,133 |